ANALYSIS: Is Smiths City’s voluntary administration the last straw for the investment group?
ANALYSIS: There are growing fears climate-related disclosures regime could further strangle NZ’s capital markets.
ANALYSIS: Why has a maelstrom blown up over what is essentially a small government contract?
ANALYSIS: Three proposed waste-to-energy thermal plants want to become NZ’s first.
ANALYSIS: Lack of presales, reluctant funders, construction challenges leading to world of pain for small-scale residential developers.
ANALYSIS: Kevin Bowler’s unexpected resignation as CEO last month gives much-maligned company a golden opportunity.
ANALYSIS: One medical provider speaks out; Southern Cross says it’s no bully.
ANALYSIS: Or do they? Supermarkets and suppliers locked in battle of wits.
ANALYSIS: Let Douglas Pharmaceuticals not be an outlier in New Zealand’s promising health tech sector.
ANALYSIS: Headwinds as strong as ever despite listed companies reporting generally positive financial results.